About the Estradiol Test
Purpose of the test
Estradiol testing helps confirm or rule out hormonal imbalances in both women and men. You might consider it when symptoms like irregular periods, infertility, early or delayed puberty, or signs of too much or too little estrogen point to a hormonal cause.
The test serves two purposes:
- Diagnosis: Ordered when symptoms suggest ovarian dysfunction, hypogonadism, premature ovarian insufficiency (POI), estrogen-producing tumors, or hypothalamic amenorrhea (when periods stop due to excessive exercise, stress, or undereating).
- Monitoring: Tracks estradiol levels in people on hormone replacement therapy (HRT), gender-affirming hormone therapy, or undergoing ovarian stimulation for in vitro fertilization (IVF).
In women, estradiol supports uterine growth, breast development, menstrual regulation, and ovulation. Levels shift across the menstrual cycle and drop at menopause. In men, estradiol is produced through the conversion (aromatization) of testosterone. It supports bone density and sperm function, as described by the Endocrine Society’s reproductive hormone library. Testing matters for gynecomastia (breast tissue growth) workup, hypogonadism checks, and monitoring men on testosterone replacement therapy.
Transgender women and nonbinary individuals on gender-affirming estrogen therapy use regular estradiol testing to keep levels in a target range. During IVF, estradiol is measured every one to two days during ovarian stimulation to track follicle growth and guide medication dosing.
When a provider orders an “estrogen test,” they almost always mean estradiol (E2). It’s the form that’s active during reproductive years. Estrone (E1) and estriol (E3) are measured only in specific contexts: estriol is the estrogen measured in pregnancy screening panels, not estradiol.
The test doesn’t measure estrone or estriol unless separately ordered. It won’t diagnose infertility, polycystic ovary syndrome (PCOS), or menopause on its own. Results need to be read alongside FSH, LH, and your clinical history. It doesn’t replace imaging or biopsy for suspected estrogen-producing tumors either.
What does the estradiol test measure?
This test covers one marker from a single blood sample processed at a CLIA-certified lab.
Reproductive Hormones
- Estradiol (E2): The primary and most potent form of estrogen, produced mainly by the ovaries in women and through testosterone conversion in men.
Labs use two main methods to measure estradiol. The one your provider orders matters.
- Standard immunoassay (ECLIA): The most common method for women of reproductive age. It works well in the mid-to-high range but loses accuracy below roughly 20 pg/mL. That makes it less reliable for men, postmenopausal women, children, and people on low-dose hormone therapy.
- LC-MS/MS (sensitive or ultrasensitive estradiol test): The preferred method when accurate measurement at low levels is needed. According to research published in the Journal of Clinical Endocrinology & Metabolism, mass spectrometry methods require sex- and age-specific reference ranges to be clinically useful. Providers order it for men, children, postmenopausal women, and people on low-dose estrogen therapy. It’s more precise at the low end and may take slightly longer to process.
- Estradiol-17β (17-beta estradiol): The specific molecular form both methods measure. Some lab reports list “estradiol-17β” or “E2.” These all refer to the same thing.
- Serum vs. plasma: Most labs run estradiol on a serum sample (from a standard red- or gold-top tube). Some use plasma. Tube color varies by lab.
Standard immunoassay covers most routine testing. If your provider orders a “sensitive” or “ultrasensitive” estradiol test, that means LC-MS/MS. The same prep applies.
When should I get an estradiol test?
Consider testing if any of these apply:
- Difficulty getting pregnant or a known fertility concern (an Anti-Müllerian Hormone (AMH) Test may also be ordered to assess ovarian reserve)
- Gynecomastia or unexplained bone loss in men
- Irregular, missed, or very heavy periods
- Signs of early or delayed puberty in children or adolescents
- Symptoms of too much estrogen: breast tenderness, bloating, or irregular bleeding
- Symptoms of low estrogen: hot flashes, night sweats, vaginal dryness, or bone loss
- Current or planned hormone therapy (HRT, gender-affirming estrogen therapy, or testosterone replacement therapy)
There’s no CDC or USPSTF population-level screening recommendation for estradiol in people without symptoms. The American Society for Reproductive Medicine’s diagnostic evaluation guidelines outline when estradiol testing is appropriate as part of a fertility workup. Routine testing is for people already in a care pathway:
For routine monitoring:
- Men on testosterone replacement therapy: periodic testing because excess testosterone can convert to estradiol
- People undergoing IVF or ovarian stimulation: serial monitoring every one to two days during the stimulation protocol
- Perimenopausal women with symptoms: baseline testing alongside FSH to check the menopausal transition
- Transgender women and nonbinary individuals on gender-affirming estrogen therapy: regular monitoring to keep levels in the target range
- Women on HRT for menopause: periodic monitoring per provider guidance
How It Works
How to get tested
Ask your provider for an estradiol blood test. Most providers order it through CLIA-certified labs, including LabCorp and Quest Diagnostics. A phlebotomist draws blood from a vein in your arm at a lab or your provider’s office. Results come back through the ordering provider’s patient portal or office.
Timing matters if you have regular cycles. For a baseline reading, cycle days two through four are preferred. If you don’t have regular periods, the test can be done any time. If estradiol is part of a broader hormone panel, follow that panel’s prep instructions, since some panels require fasting.
Before the test
Eat and drink normally. No fasting is needed for a standalone estradiol test. If estradiol is part of a broader hormone or metabolic panel, follow the panel’s fasting instructions, often eight to 12 hours for panels that include glucose or insulin markers.
If you have regular cycles, schedule your draw on cycle days two, three, or four. Estradiol shifts a lot across the cycle, so this timing gives the most accurate baseline. If you don’t have regular periods, any time works.
Tell your provider about all medications and supplements before testing. Substances that can change your results include:
- Clomiphene (Clomid)
- GnRH agonists or antagonists (leuprolide, ganirelix)
- Herbal supplements with estrogenic activity, like black cohosh and soy isoflavones
- Hormonal contraceptives (birth control pills, patches, rings)
- Hormone replacement therapy (HRT)
These can suppress your body’s own estradiol or change measured levels, making results harder to read. Don’t stop any medication without talking to your provider first.
Morning collection is generally preferred for hormone testing.
During the test
- Bring a photo ID and your order confirmation. Check in at the patient service center.
- A phlebotomist cleans a small area on your inner arm and inserts a thin needle into a vein. You’ll feel a brief pinch.
- The draw takes about one to two minutes. One tube of blood is collected.
- A small bandage covers the site. No recovery time needed.
There’s no solution to drink and no multiple blood draws. This is a standard blood draw.
You may feel a brief sting when the needle goes in. Some people feel lightheaded afterward. If that happens, tell the phlebotomist before you stand up.
Keep the bandage on for at least 15 minutes. Mild bruising at the site is normal and clears up in a few days. Call your provider if you notice lasting pain, swelling, redness, or signs of infection.
After the test
Results are typically ready within one to three business days after the lab receives your sample, though timing can vary by lab. Standard immunoassay results usually come back within one to two business days. LC-MS/MS assays may take up to three business days.
Results come through the ordering provider’s patient portal or office. Talk with your provider about what your numbers mean given your symptoms, cycle timing, and any medications you’re taking.
What Do My Results Mean?
Estradiol results are reported in picograms per milliliter (pg/mL). What the number means depends on your sex, age, and where you are in your menstrual cycle. A level that’s normal at mid-cycle would be high in a postmenopausal woman. Context matters.
The ranges below are approximate and vary between labs. Your lab report will list the specific reference range used.
| Population | Estradiol Reference Range (pg/mL) |
| Women: follicular phase (days 1–13) | 19–144 pg/mL |
| Women: mid-cycle peak (ovulation) | 64–357 pg/mL |
| Women: luteal phase (days 15–28) | 56–214 pg/mL |
| Women: postmenopausal | Less than 10 pg/mL |
| Men (adults) | 10–40 pg/mL |
| Children (prepubertal) | Undetectable to 20 pg/mL |
Ranges are approximate. Verify against your lab’s specific reference intervals.
A level of 50 pg/mL is normal in the early follicular phase but would be low at the LH surge. A level of 200 pg/mL is normal at mid-cycle but would raise concern in a postmenopausal woman. For men, the standard immunoassay may not be accurate at low levels. If your result is near the lower limit, ask your provider whether an LC-MS/MS assay would be more accurate.
If your results are normal
Your estradiol falls within the expected range for your sex, age, and cycle phase. A normal result doesn’t rule out every hormonal condition. If symptoms continue, follow-up testing for FSH, LH, progesterone, or thyroid function may help find what’s going on.
For people on hormone therapy, “normal” means levels are in the target range your provider set for your treatment goals.
If your results are low
In a woman of reproductive age, low estradiol may point to:
- Hypothalamic amenorrhea, often linked to excessive exercise, undereating, or chronic stress
- Hypopituitarism (low hormone output from the pituitary gland)
- Perimenopause or menopause transition, especially if FSH is high
- Premature ovarian insufficiency (POI)
In postmenopausal women, low estradiol is expected. Very low levels may lead to a conversation about bone density monitoring.
In men, low estradiol can contribute to bone loss and may lead to a check for hypogonadism.
Follow-up testing often includes FSH and LH to tell apart ovarian and pituitary causes. Imaging may follow if a pituitary cause is suspected.
If your results are high
In women, high estradiol may point to:
- An estrogen-producing ovarian tumor
- Liver disease, which slows estrogen clearance
- Normal mid-cycle peak if timed to ovulation
- Obesity, since fat tissue converts androgens to estrogen
- Certain medications
In men, high estradiol can cause gynecomastia, reduced libido, and erectile dysfunction. Common causes include obesity, liver disease, testicular tumors, or excess aromatization in men on testosterone replacement therapy, as outlined in Cleveland Clinic’s overview of estradiol in men.
In children, high estradiol may signal precocious (early) puberty.
Your provider will review the result in context. Imaging may be ordered to rule out an estrogen-secreting tumor. A medication review is part of the workup.
FAQs
Sources
Endocrine Society. Estrogen. Endocrine Library.
American Society for Reproductive Medicine. Diagnostic Evaluation of the Infertile Female.